共 50 条
- [41] DOES DURATION OF DISEASE AFFECT PATIENT RESPONSE TO 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS (RA) ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S178 - S178
- [42] RISK-FACTORS FOR THE DISCONTINUATION OF 2ND-LINE ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - A PROSPECTIVE ANALYSIS BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 207 - 207
- [43] INTERFERON-GAMMA IN THE THERAPY OF RHEUMATOID-ARTHRITIS - LONG-TERM THERAPY IN PRACTICE ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1989, 39-2 (07): : 819 - 822
- [44] MORBIDITY ASSOCIATED WITH LONG-TERM METHOTREXATE THERAPY IN JUVENILE RHEUMATOID-ARTHRITIS JOURNAL OF PEDIATRICS, 1992, 120 (03): : 468 - 473
- [45] THE SAFETY AND EFFICACY OF THE USE OF METHOTREXATE IN LONG-TERM THERAPY FOR RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1986, 29 (07): : 822 - 831
- [46] EFFECT OF LONG-TERM THERAPY WITH TRANSFER-FACTOR IN RHEUMATOID-ARTHRITIS REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1985, 23 (02): : 135 - 140
- [47] FLURBIPROFEN IN RHEUMATOID-ARTHRITIS - A LONG-TERM EXPERIENCE CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (03): : 423 - 427
- [50] LONG-TERM EXPERIENCE WITH NABUMETONE IN RHEUMATOID-ARTHRITIS CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1984, 36 (03): : 582 - 587